MDClone chosen as one of the 100 most promising Technology Pioneers of 2021 for its powerful MDClone ADAMS Platform enabling healthcare workers to deliver better patient care.
BE’ER-SHEVA, Israel, 15 June, 2021 – MDClone, a leading healthcare data analytics company, was selected among hundreds of candidates as one of the World Economic Forum’s “Technology Pioneers.” Founded in Israel in 2016, MDClone is dramatically improving the healthcare data space with its self-service analytics environment enabling users to access, organize, explore, and share healthcare data and discoveries while maintaining patient privacy.
The MDClone ADAMS Platform provides health systems and life science organizations the ability to accelerate research, improve operations and quality, and drive innovation. Healthcare workers can explore data freely to discover trends, improve quality, drive revenue, reduce costs, and implement change. In addition, through synthetic data capabilities, users are able to share insights across organizations or to external parties in a secure fashion.
The World Economic Forum’s Technology Pioneers are early to growth-stage companies from around the world that are involved in the use of new technologies and innovation that are poised to have a significant impact on business and society.
“We’re excited to welcome MDClone to our 2021 cohort of Technology Pioneers,” says Susan Nesbitt, Head of the Global Innovators Community, World Economic Forum. “MDClone and its fellow pioneers are developing technologies that can help society solve some of its most pressing issues. We look forward to their contribution to the World Economic Forum in its commitment to improving the state of the world.”
With the company’s selection as Technology Pioneer, Founder and CEO Ziv Ofek of MDClone has been invited to participate in the World Economic Forum activities, events, and discussions throughout the year. MDClone will also contribute to Forum initiatives over the next two years, working with global leaders to help address key industry and societal issues.
“We are honored to be counted as a pioneer by the World Economic Forum,” said Ofek. “This recognition speaks to the incredible potential and need to connect innovative technology to the clinical staff who are empowered to transform healthcare. We are thrilled to continue working with some of the world’s most innovative healthcare organizations who are transforming the way care is accessed and insights are put into action.”
Amid major global issues brought about by the COVID-19 pandemic, it is a critical moment for innovative companies to bring forward new ideas and innovations to help protect the lives and livelihoods of communities and industries around the world.
Washington University in St. Louis has worked with MDClone since 2018 and is the company’s first collaborator in North America. The university is at the forefront of using big data to speed up research, with the goal of improving the diagnosis and treatment of illness.
“MDClone’s innovative synthetic data platform produces data that is statistically identical to data from real patients but preserves patient privacy because this data can’t be associated with individual patients,” said Philip R. O. Payne, PhD, chief data scientist and director of the Institute for Informatics at Washington University School of Medicine. “This has opened the door to using synthetic data to quickly ask and answer important research questions that can improve the care we provide to patients and the health of the communities we serve. We look forward to seeing MDClone’s continued and expanded efforts to enable data-driven research and innovation, particularly at a global level.”
Technology Pioneers were selected based on the community’s selection criteria, which includes innovation, impact, and leadership as well as the company’s relevance with the World Economic Forum’s Platforms.
